Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
Creator
Hughes, Mark
Angiari, Stefano
Banahan, Kathy
Corcoran, Sarah
Fischer, Roman
Hester, Svenja
Hooftman, Alexander
Irvine, Alan
Ling, Chris
Mcgettrick, Anne
O'neill, Luke
Runtsch, Marah
Ruzek, Melanie
Slivka, Peter
Source
Elsevier; Medline; PMC
abstract
The Krebs cycle-derived metabolite itaconate is highly upregulated in inflammatory macrophages and exerts immunomodulatory effects through cysteine modifications on target proteins. The NLRP3 inflammasome, which cleaves IL-1β, IL-18, and gasdermin D, must be tightly regulated to avoid excessive inflammation. Here we provide evidence that itaconate modifies NLRP3 and inhibits inflammasome activation. Itaconate and its derivative, 4-octyl itaconate (4-OI), inhibited NLRP3 inflammasome activation, but not AIM2 or NLRC4. Conversely, NLRP3 activation was increased in itaconate-depleted Irg1(−/−) macrophages. 4-OI inhibited the interaction between NLRP3 and NEK7, a key step in the activation process, and “dicarboxypropylated” C548 on NLRP3. Furthermore, 4-OI inhibited NLRP3-dependent IL-1β release from PBMCs isolated from cryopyrin-associated periodic syndrome (CAPS) patients, and reduced inflammation in an in vivo model of urate-induced peritonitis. Our results identify itaconate as an endogenous metabolic regulator of the NLRP3 inflammasome and describe a process that may be exploited therapeutically to alleviate inflammation in NLRP3-driven disorders.
has issue date
2020-08-12
(
xsd:dateTime
)
bibo:doi
10.1016/j.cmet.2020.07.016
bibo:pmid
32791101
has license
no-cc
sha1sum (hex)
a759c35d627e65b3ff2debc68c5ff1a7c65a4982
schema:url
https://doi.org/10.1016/j.cmet.2020.07.016
resource representing a document's title
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
has PubMed Central identifier
PMC7422798
has PubMed identifier
32791101
schema:publication
Cell Metab
resource representing a document's body
covid:a759c35d627e65b3ff2debc68c5ff1a7c65a4982#body_text
is
schema:about
of
named entity 'inflammasome'
covid:arg/a759c35d627e65b3ff2debc68c5ff1a7c65a4982
named entity 'activation'
named entity 'itaconate'
named entity 'IL-1b'
named entity 'NLRP3'
named entity 'FlowJo'
named entity 'inflammasomes'
named entity 'sodium orthovanadate'
named entity 'S3G'
named entity 'immune complexes'
named entity 'CD45'
named entity 'unsaturated'
named entity 'cyclised'
named entity 'immune complexes'
named entity 'Bioinformatics'
named entity 'Addgene'
named entity 'NLRP3'
named entity 'NLRP3'
named entity 'caspase-4'
named entity 'gradient elution'
named entity 'IL-1b'
named entity 'pyroptosis'
named entity 'IL-18'
named entity 'negative ion'
named entity 'itaconate'
named entity 'PBS'
named entity 'insoluble'
named entity 'PBS'
named entity 'itaconate'
named entity 'non-significant'
named entity 'Biochemistry'
named entity 'FACS'
named entity 'octyl'
named entity 'IgG antibody'
named entity 'NLRP3'
named entity 'S1C'
named entity 'inflammasome'
named entity 'NLRP3'
named entity 'NLRP3'
named entity 'carboxy-terminal'
named entity 'protein'
named entity 'pyroptosis'
named entity 'NLRP3'
named entity 'LPS'
named entity 'crosslinking'
named entity 'NLRC4'
named entity 'inflammasome'
named entity 'murine'
named entity 'mice'
named entity 'Oxidation'
named entity 'Escherichia coli'
named entity 'caspase-1'
named entity 'DMEM'
named entity 'cell lysate'
named entity 'NLRP3'
named entity 'HEPES'
named entity 'mononuclear cells'
named entity 'itaconate'
named entity 'organ'
named entity 'centrifuged'
named entity 'erythroid'
named entity 'streptomycin'
named entity 'octyl'
named entity 'supernatant'
named entity 'RPMI'
named entity 'IL-1b'
named entity 'confidence interval'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 13
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software